Organon & Co
821 hedge funds and large institutions have $5.59B invested in Organon & Co in 2022 Q4 according to their latest regulatory filings, with 127 funds opening new positions, 217 increasing their positions, 341 reducing their positions, and 81 closing their positions.
153% more call options, than puts
Call options by funds: $32M | Put options by funds: $12.7M
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
57% more first-time investments, than exits
New positions opened: 127 | Existing positions closed: 81
22% more capital invested
Capital invested by funds: $4.57B → $5.59B (+$1.02B)
4% more funds holding
Funds holding: 791 → 821 (+30)
1.16% more ownership
Funds ownership: 76.59% → 77.75% (+1.2%)
36% less repeat investments, than reductions
Existing positions increased: 217 | Existing positions reduced: 341
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$60.9M |
| 2 |
Amundi
Paris,
France
|
+$43.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.7M |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
+$24.1M |
| 5 |
Impax Asset Management Group
London,
United Kingdom
|
+$19.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$91.3M |
| 2 |
JP Morgan Chase
New York
|
-$29.2M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$18.2M |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$17.6M |
| 5 |
SAM
Soviero Asset Management
New York
|
-$13.5M |
OGN Hedge Fund Activity: Q4 2022 in Review
821 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q4 2022, worth a combined $5.59B — up 22% from $4.57B a quarter earlier.
Buyers outnumbered sellers: 127 funds opened new OGN positions and 81 closed out — a net gain of 46 holders — while 217 added to existing stakes and 341 trimmed.
The largest buyer was Mawer Investment Management, adding an estimated $60.9M. The largest seller was Bank of New York Mellon, cutting an estimated $91.3M.
- 821 institutional investors held Organon & Co (OGN) as of Q4 2022, up from 791 in Q3 2022.
- Funds reported $5.59B of Organon & Co stock for Q4 2022, up 22% quarter-over-quarter.
- 127 funds opened new Organon & Co positions in Q4 2022 and 81 closed out, a net change of +46 holders.
- The largest Organon & Co buyer in Q4 2022 was Mawer Investment Management, an estimated $60.9M added.
- The largest Organon & Co seller in Q4 2022 was Bank of New York Mellon, an estimated $91.3M sold.
Based on aggregated 13F filings for Q4 2022.